
Lantern Pharma Investor Relations Material
Latest events

Q4 2024
Lantern Pharma
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Lantern Pharma Inc
Access all reports
Lantern Pharma is a clinical stage biotechnology company whose clinical programs target patients that have limited or poor options. Lantern's revolutionary AI platform, RADR®, uses leading edge machine learning techniques to help optimize drug development and clinical trial design, identify potential new indications for approved drugs, and improve the success of oncology clinical trials.
Key slides for Lantern Pharma Inc


Q2 2024
Lantern Pharma Inc


Q4 2024
Lantern Pharma Inc
Latest articles
)
Lowe's Companies: Building a One-Stop Shop for Home Improvement
Lowe's Companies began as a single store in 1921 and has steadily expanded its footprint and offerings, now operating 1,750 stores across the U.S.
7 May 2025
)
Greg Abel: Succeeding Warren Buffett at Berkshire Hathaway
After decades working with Warren Buffett and Charlie Munger, Greg Abel was named Buffett’s successor as he steps down in late 2025.
5 May 2025
)
Intuitive Surgical: Enhancing Surgery with Robotic Precision
Intuitive Surgical has revolutionized surgery with robotics, building its dominant position through decades of innovation, validation, and expansion.
2 May 2025
Ticker symbol
LTRN
Country
🇺🇸 United States